How CBD and Low-Dose THC From Hemp Products Affect Drug Tests and the Body
In 60 healthy adults, daily CBD with trace THC amounts found in legal hemp products could trigger positive drug tests, with effects varying by THC dose level.
Quick Facts
What This Study Found
Even small amounts of THC in legal hemp CBD products (0.5-3.7 mg) could lead to positive drug tests after repeated use, with pharmacokinetic and pharmacodynamic effects varying by dose.
Key Numbers
60 healthy adults, 6 groups of 10, receiving 100 mg CBD with 0, 0.5, 1, 2, 2.8, or 3.7 mg THC. Includes 8-hour acute session plus 14-day outpatient exposure.
How They Did This
Controlled clinical study with 60 healthy adults self-administering 100 mg CBD with varying THC doses (0-3.7 mg) across an acute lab session and 14-day outpatient period, measuring pharmacokinetics and drug test results.
Why This Research Matters
Millions use legal hemp CBD products assuming they won't affect drug tests. This controlled study shows that even compliant hemp products can lead to positive tests, with real consequences for employment and legal situations.
The Bigger Picture
The legal distinction between hemp (≤0.3% THC) and marijuana creates a false sense of safety regarding drug testing. This study provides concrete data on how legal products can still cause problems in drug-testing scenarios.
What This Study Doesn't Tell Us
Controlled MCT oil formulation may differ from commercial products. 60 participants across 6 groups means only 10 per condition. Individual metabolism varies.
Questions This Raises
- ?Should drug testing protocols be updated to account for legal hemp product use?
- ?What THC threshold in hemp products truly prevents positive drug tests?
Trust & Context
- Key Stat:
- Evidence Grade:
- Well-controlled clinical trial with multiple dose groups providing strong pharmacokinetic evidence, though moderate sample per group.
- Study Age:
- Recent study addressing a practical concern for the growing number of legal hemp CBD product users.
- Original Title:
- The Acute and Chronic Pharmacokinetics and Pharmacodynamics of Oral Cannabidiol (CBD) With and Without Low Doses of Delta-9-Tetrahydrocannabinol (Δ9-THC).
- Published In:
- Journal of analytical toxicology (2025)
- Authors:
- Wolinsky, David(5), Zamarripa, C Austin(9), Spindle, Tory R(18), Klausner, McKenna, Cone, Edward J, Winecker, Ruth E, Vikingsson, Svante, Flegel, Ronald R, Hayes, Eugene D, Davis, Lisa S, Kuntz, David, Bonn-Miller, Marcel, Bigelow, George E, Vandrey, Ryan
- Database ID:
- RTHC-07964
Evidence Hierarchy
Frequently Asked Questions
Can legal CBD products make you fail a drug test?
Yes — this study shows that even products meeting the legal THC limit (≤0.3%) can lead to positive drug tests after regular use, particularly at the higher end of allowable THC content.
How much THC does it take to trigger a positive test?
In this study, even 0.5 mg of THC alongside 100 mg CBD was tested. The risk increases with higher THC amounts and repeated daily use over the 14-day period.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- how-much-money-spent-on-weed-calculator
- thc-drinks-vs-edibles-body-processes
- homemade-vs-store-bought-edibles-safety
- how-to-store-edibles-shelf-life-potency
- cannabis-dosing-guide-how-much-thc
- what-is-tincture-different-from-edible
- sublingual-vs-oral-vs-inhaled-thc-absorption
- employer-drug-test-thc-2026
- flying-with-weed-tsa-rules-state-lines
- cannabis-military-rules-testing-career
- cannabis-security-clearances-federal-government
- why-does-weed-hit-different-sometimes
- how-to-avoid-greening-out-dosing-prevention
- thc-clearance-calculator-when-weed-leave-system
- thc-detox-calculator-how-long-to-get-clean
- cannabis-cost-calculator-how-much-spending
- cannabis-cost-calculator-what-youre-really-spending
Cite This Study
https://rethinkthc.com/research/RTHC-07964APA
Wolinsky, David; Zamarripa, C Austin; Spindle, Tory R; Klausner, McKenna; Cone, Edward J; Winecker, Ruth E; Vikingsson, Svante; Flegel, Ronald R; Hayes, Eugene D; Davis, Lisa S; Kuntz, David; Bonn-Miller, Marcel; Bigelow, George E; Vandrey, Ryan. (2025). The Acute and Chronic Pharmacokinetics and Pharmacodynamics of Oral Cannabidiol (CBD) With and Without Low Doses of Delta-9-Tetrahydrocannabinol (Δ9-THC).. Journal of analytical toxicology. https://doi.org/10.1093/jat/bkaf075
MLA
Wolinsky, David, et al. "The Acute and Chronic Pharmacokinetics and Pharmacodynamics of Oral Cannabidiol (CBD) With and Without Low Doses of Delta-9-Tetrahydrocannabinol (Δ9-THC).." Journal of analytical toxicology, 2025. https://doi.org/10.1093/jat/bkaf075
RethinkTHC
RethinkTHC Research Database. "The Acute and Chronic Pharmacokinetics and Pharmacodynamics ..." RTHC-07964. Retrieved from https://rethinkthc.com/research/wolinsky-2025-the-acute-and-chronic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.